Treatment of Diffuse Large B-Cell Lymphoma
Author:
Affiliation:
1. Department of Hematology and Oncology, Mie University Graduate School of Medicine
Publisher
Japanese Society for Lymphoreticular Tissue Research
Subject
General Medicine
Link
https://www.jstage.jst.go.jp/article/jslrt/56/2/56_79/_pdf
Reference63 articles.
1. 1 WHO Classification of Tumours, Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (eds): 4th ed, Lyon, IARC, 2008
2. 2 Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, et al.: A revised European-American classification of lymphoid neo-plasms: a proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
3. 3 A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
4. 4 Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, et al.: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin’s lymphoma. N Engl J Med 339:21-26, 1998
5. 5 Bonnet C, Fillet G, Mounier N, Ganem G, Molina TJ, et al.: CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 25:787-792, 2007
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diffuse Large B Cell Lymphoma of Spleen: An Important Differential of a Nodular Splenomegaly: A Case Report;EMJ Hematology;2024-07-25
2. Lymphomas of the Vulva: A Review of the MITO Rare Cancer Group;Cancers;2024-05-31
3. Лечение диффузной В-крупноклеточной лимфомы в условиях ГКБ № 52 Департамента здравоохранения Москвы: ретроспективное клиническое исследование, отражающее опыт одного центра, на основе анализа данных из собственного локального регистра;Clinical Oncohematology;2024-02-20
4. A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell Lymphoma;PharmacoEconomics - Open;2024-01-10
5. Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma;Blood Cancer Journal;2023-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3